Optic neuritis: Difference between revisions
Jump to navigation
Jump to search
| Line 70: | Line 70: | ||
=== Incidence === | === Incidence === | ||
* The incidence of optic neuritis is approximately 5 to 6.4 per 100 000 individuals in US. | * The incidence of optic neuritis is approximately 5 to 6.4 per 100 000 individuals in US.<ref name="pmid3178158">{{cite journal |vauthors=Marechal F, Berthiot G, Deltour G |title=Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung |journal=Anticancer Res. |volume=8 |issue=4 |pages=677–80 |date=1988 |pmid=3178158 |doi= |url=}}</ref><ref name="pmid7854520">{{cite journal |vauthors=Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT |title=Optic neuritis: a population-based study in Olmsted County, Minnesota |journal=Neurology |volume=45 |issue=2 |pages=244–50 |date=February 1995 |pmid=7854520 |doi= |url=}}</ref><ref name="pmid5057861">{{cite journal |vauthors=Percy AK, Nobrega FT, Kurland LT |title=Optic neuritis and multiple sclerosis. An epidemiologic study |journal=Arch. Ophthalmol. |volume=87 |issue=2 |pages=135–9 |date=February 1972 |pmid=5057861 |doi= |url=}}</ref> | ||
=== Age === | === Age === | ||
* | * Optic neuritis commonly affects patients between the ages of 15 and 49.<ref name="pmid3105615">{{cite journal |vauthors=Self SG, Grossman EA |title=Linear rank tests for interval-censored data with application to PCB levels in adipose tissue of transformer repair workers |journal=Biometrics |volume=42 |issue=3 |pages=521–30 |date=September 1986 |pmid=3105615 |doi= |url=}}</ref> | ||
=== Race === | === Race === | ||
* Optic neuritis usually affects individuals of the Caucasians race eight times more frequently than blacks and Asians. | * Optic neuritis usually affects individuals of the Caucasians race eight times more frequently than blacks and Asians.<ref name="pmid3178158">{{cite journal |vauthors=Marechal F, Berthiot G, Deltour G |title=Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung |journal=Anticancer Res. |volume=8 |issue=4 |pages=677–80 |date=1988 |pmid=3178158 |doi= |url=}}</ref> | ||
* Black populations individuals are less likely to develop optic neuritis. | * Black populations individuals are less likely to develop optic neuritis.<ref name="pmid3178158">{{cite journal |vauthors=Marechal F, Berthiot G, Deltour G |title=Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung |journal=Anticancer Res. |volume=8 |issue=4 |pages=677–80 |date=1988 |pmid=3178158 |doi= |url=}}</ref><ref name="pmid9482360">{{cite journal |vauthors=Phillips PH, Newman NJ, Lynn MJ |title=Optic neuritis in African Americans |journal=Arch. Neurol. |volume=55 |issue=2 |pages=186–92 |date=February 1998 |pmid=9482360 |doi= |url=}}</ref><ref name="pmid17967837">{{cite journal |vauthors=Bhigjee AI, Moodley K, Ramkissoon K |title=Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study |journal=Mult. Scler. |volume=13 |issue=9 |pages=1095–9 |date=November 2007 |pmid=17967837 |doi=10.1177/1352458507079274 |url=}}</ref><ref name="pmid17967837">{{cite journal |vauthors=Bhigjee AI, Moodley K, Ramkissoon K |title=Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study |journal=Mult. Scler. |volume=13 |issue=9 |pages=1095–9 |date=November 2007 |pmid=17967837 |doi=10.1177/1352458507079274 |url=}}</ref><ref name="pmid2124032">{{cite journal |vauthors=Mbonda E, Larnaout A, Maertens A, Appel B, Lowenthal A, Mbede J, Evrard P |title=Multiple sclerosis in a black Cameroonian woman |journal=Acta Neurol Belg |volume=90 |issue=4 |pages=218–22 |date=1990 |pmid=2124032 |doi= |url=}}</ref> | ||
=== Gender === | === Gender === | ||
| Line 87: | Line 83: | ||
=== Region === | === Region === | ||
* The incidence of optic neuritis is highest in populations located at higher latitudes such as: | * The incidence of optic neuritis is highest in populations located at higher latitudes such as:<ref name="pmid3178158">{{cite journal |vauthors=Marechal F, Berthiot G, Deltour G |title=Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung |journal=Anticancer Res. |volume=8 |issue=4 |pages=677–80 |date=1988 |pmid=3178158 |doi= |url=}}</ref><ref name="pmid19878630">{{cite journal |vauthors=Shams PN, Plant GT |title=Optic neuritis: a review |journal=Int MS J |volume=16 |issue=3 |pages=82–9 |date=September 2009 |pmid=19878630 |doi= |url=}}</ref><ref name="pmid4015470">{{cite journal |vauthors=Kurtzke JF |title=Optic neuritis or multiple sclerosis |journal=Arch. Neurol. |volume=42 |issue=7 |pages=704–10 |date=July 1985 |pmid=4015470 |doi= |url=}}</ref> | ||
** Northern United States | ** Northern United States | ||
** Northern and Western Europe | ** Northern and Western Europe | ||
Revision as of 19:09, 9 November 2018
|
WikiDoc Resources for Optic neuritis |
|
Articles |
|---|
|
Most recent articles on Optic neuritis Most cited articles on Optic neuritis |
|
Media |
|
Powerpoint slides on Optic neuritis |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Optic neuritis at Clinical Trials.gov Trial results on Optic neuritis Clinical Trials on Optic neuritis at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Optic neuritis NICE Guidance on Optic neuritis
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Optic neuritis Discussion groups on Optic neuritis Patient Handouts on Optic neuritis Directions to Hospitals Treating Optic neuritis Risk calculators and risk factors for Optic neuritis
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Optic neuritis |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Historical Perspective
Discovery
- Optic neuritis was first discovered by von Graefe and Nettleship, in late nineteenth century when ophthalmoscopy became part of the ophthalmic examination.[1]
- The association between systemic sclerosis and optic neuritis was made by the early 1900's but there was much controversy and misunderstanding about its differential diagnosis, pathogenesis, and possible treatment.[1]
- Optic neuritis was first distinguished from infectious,hereditary, toxic, nutritional, and ischemic optic neuropathies during the twentieth century.[1]
- During late twentieth century, the development of MRI and the results from recent clinical trials, discovered the relationship between optic neuritis and multiple sclerosis.[1]
Classification
Optic neuritis may be classified into atypical or typical subtypes based on its clinical features.[2]
- Atypical optic neuritis entails clinical manifestations that deviate from classic pattern of optic neuritis features.[3]
- Atypical features to consider include:[3]
- Lack of pain
- Simultaneous or near-simultaneous onset
- Lack of response to or relapse upon tapering from corticosteroids
- Optic neuritis due nerve head or peripapillary hemorrhages
Pathophysiology
Pathogenesis
- The exact pathogenesis of optic neuritis is not completely understood.[4][5]
- But It is likely due to some inflammatory process which leads to delayed type IV hypersensitivity reaction induced by released cytokines and other inflammatory mediators from activated peripheral T-cells which can cross the blood brain barrier and cause destruction of myelin, neural cell death and axonal degeneration.[4][5]
- In addition to involvement of the myelin sheath (white matter), latest technologies such as optical coherence tomography (OCT) suggest involvement of axons (gray matter) in this process.[4][5]
- Findings suggestive of optic neuritis in microscopic histopathological analysis include:[6]
- Reduced axon counts
- Optic atrophy
- Inflammation
- Demyelination
- Axonal loss
- Intracellular neurofilaments
Causes
- The exact cause of optic neuritis is unknown.[7][8][9]
- But It is likely due invasion of the immune system to the myelin, resulting in inflammation and damage to the myelin.
The following autoimmune are associated with optic neuritis:[7][8][9]
- Multiple sclerosis:
- Multiple sclerosis is the first main cause of optic neuritis.[8]
- 50% of patients with multiple sclerosis finally develop optic neuritis.[9]
- Neuromyelitis optica
- In Neuromyelitis optica, inflammation recurs in the optic nerve and spinal cord.
- Infections:
Differentiating Optic Neuritis from other Diseases
Optic neuritis must be differentiated from other diseases that cause sudden eye pain and vision loss such as:[2]
- Leber’s Hereditary Optic Neuropathy (LHON)[2] which results from point mutations in mitochondrial DNA and subsequent mitochondrial dysfunction, causing bilateral central vision loss.[10]
- Nonarteritic Anterior Ischemic Optic Neuropathy (AION)[2]
- It is the most common form of ischemic optic neuropathy and the second most common optic neuropathy.
- It is more common in patients over the age of 50 years with vasculopathic risk factors such as:
Epidemiology and Demographics
Incidence
Age
- Optic neuritis commonly affects patients between the ages of 15 and 49.[13]
Race
- Optic neuritis usually affects individuals of the Caucasians race eight times more frequently than blacks and Asians.[7]
- Black populations individuals are less likely to develop optic neuritis.[7][14][15][15][16]
Gender
- Women are more commonly affected by optic neuritis than men.[2]
Region
- The incidence of optic neuritis is highest in populations located at higher latitudes such as:[7][17][18]
- Northern United States
- Northern and Western Europe
- New Zealand and Southern Australia)
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
References
- ↑ 1.0 1.1 1.2 1.3 Volpe NJ (December 2001). "Optic neuritis: historical aspects". J Neuroophthalmol. 21 (4): 302–9. PMID 11756864.
- ↑ 2.0 2.1 2.2 2.3 2.4 Kliethermes MA (July 1988). "Working parents in two-pharmacist marriages". Am J Hosp Pharm. 45 (7): 1500. PMID 3414716.
- ↑ 3.0 3.1 Gaier ED, Boudreault K, Rizzo JF, Falardeau J, Cestari DM (December 2015). "Atypical Optic Neuritis". Curr Neurol Neurosci Rep. 15 (12): 76. doi:10.1007/s11910-015-0598-1. PMID 26467052.
- ↑ 4.0 4.1 4.2 Hoorbakht H, Bagherkashi F (2012). "Optic neuritis, its differential diagnosis and management". Open Ophthalmol J. 6: 65–72. doi:10.2174/1874364101206010065. PMC 3414716. PMID 22888383.
- ↑ 5.0 5.1 5.2 Toosy AT, Mason DF, Miller DH (January 2014). "Optic neuritis". Lancet Neurol. 13 (1): 83–99. doi:10.1016/S1474-4422(13)70259-X. PMID 24331795.
- ↑ Taniguchi S, Kawano T, Kakunaga T, Baba T (May 1986). "Differences in expression of a variant actin between low and high metastatic B16 melanoma". J. Biol. Chem. 261 (13): 6100–6. PMID 3700386.
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 Marechal F, Berthiot G, Deltour G (1988). "Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung". Anticancer Res. 8 (4): 677–80. PMID 3178158.
- ↑ 8.0 8.1 8.2 Bourdial J (April 1969). "[Otorhinolaryngologic action in asthmatics]". Maroc Med (in French). 49 (523): 209–17. PMID 5398737.
- ↑ 9.0 9.1 9.2 Balcer LJ (March 2006). "Clinical practice. Optic neuritis". N. Engl. J. Med. 354 (12): 1273–80. doi:10.1056/NEJMcp053247. PMID 16554529.
- ↑ Fujimori H (December 1973). "[Pulmonary tuberculosis--keypoints in nursing of pregnant and puerperal patients]". Josanpu Zasshi (in Japanese). 27 (12): 40–3. PMID 4492634.
- ↑ Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT (February 1995). "Optic neuritis: a population-based study in Olmsted County, Minnesota". Neurology. 45 (2): 244–50. PMID 7854520.
- ↑ Percy AK, Nobrega FT, Kurland LT (February 1972). "Optic neuritis and multiple sclerosis. An epidemiologic study". Arch. Ophthalmol. 87 (2): 135–9. PMID 5057861.
- ↑ Self SG, Grossman EA (September 1986). "Linear rank tests for interval-censored data with application to PCB levels in adipose tissue of transformer repair workers". Biometrics. 42 (3): 521–30. PMID 3105615.
- ↑ Phillips PH, Newman NJ, Lynn MJ (February 1998). "Optic neuritis in African Americans". Arch. Neurol. 55 (2): 186–92. PMID 9482360.
- ↑ 15.0 15.1 Bhigjee AI, Moodley K, Ramkissoon K (November 2007). "Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study". Mult. Scler. 13 (9): 1095–9. doi:10.1177/1352458507079274. PMID 17967837.
- ↑ Mbonda E, Larnaout A, Maertens A, Appel B, Lowenthal A, Mbede J, Evrard P (1990). "Multiple sclerosis in a black Cameroonian woman". Acta Neurol Belg. 90 (4): 218–22. PMID 2124032.
- ↑ Shams PN, Plant GT (September 2009). "Optic neuritis: a review". Int MS J. 16 (3): 82–9. PMID 19878630.
- ↑ Kurtzke JF (July 1985). "Optic neuritis or multiple sclerosis". Arch. Neurol. 42 (7): 704–10. PMID 4015470.